相关实验视频
Updated: Jan 12, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
哪个更适合血糖控制? 哪个更适合血糖控制? 在败血症重症患者中进行玻尿酸,间歇性 (夜间暂停) 或连续的肠道食
1Anaesthesiology and Reanimation Department, Umraniye Education and Research Hospital, Istanbul, Turkey.
Science progress
|November 4, 2025
概括
在败血症患者中,间歇性肠道营养 (EN) 提供了更好的血糖控制,并减少了与玻尿酸或连续方法相比的食不耐受. 这项研究强调间歇性养是重症监护病房 (ICU) 中潜在的优越方法.
科学领域:
- 关键护理医学 关键护理医学
- 营养支持营养支持
- 代谢管理是代谢管理.
背景情况:
- 在ICU中的败血症患者在肠道营养 (EN) 期间经常经历低血糖症和食不耐受.
- 不同的EN方法 (球体,间歇性,连续性) 可能会对这些结果产生不同的影响.
研究的目的:
- 为了比较玻尿酸,间歇性和连续性EN对血糖水平 (BGLs) 的影响,在患有败血症的ICU患者中.
- 评估这些EN方法对食不耐症发展的影响.
主要方法:
- 一个单中心,前性,随机对照试验,涉及93名成年ICU患有败血症的患者.
- 患者被随机分为三个组:胆囊,间歇性或连续性EN.
- 血糖水平每天监测四次,持续7天,结果包括血糖控制和食不耐受.
主要成果:
- 与玻尿酸和连续方法相比,间歇养显示出更稳定的BGLs (p<0.01).
- 玻尿酸治疗组的不耐受性风险最高,间歇性治疗组的不耐受性风险最低 (p=0.014).
- 持续养需要最高的胰岛素注射量 (p=0.025),没有显著的时间差异到目标卡路里或乳糖注射.
结论:
- 与玻尿酸或连续方法相比,间歇性EN提供了卓越的血糖控制,并减少了ICU败血症患者的食不耐受.
- 建议对更大的队列进行进一步研究,以证实这些发现.
相关概念视频
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
800
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
800
Enteral Nutrition I: Orogastric and Nasogastric Feeding
1.2K
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.2K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
225
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
225
Two-Compartment Open Model: IV Bolus Administration
1.1K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
1.1K
One-Compartment Open Model for IV Bolus Administration: General Considerations
668
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
668
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
335
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
335

